InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Thompson Craig B.. Insider active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 9 reports have been logged. History available since 3 October 2022. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Thompson Craig B. is a declarant and has 9 filings in total. In the 9 sampled filings, the buy and sell amounts are 0, the period runs from 2022-10-05 to 2026-01-06, and the companies mentioned are Regeneron Pharmaceuticals, INC. and Charles River Laboratories International, INC., where he is a Director.